Blue Sea Capital Acquires SignatureMD; Five Points Capital Provides Financing
April 1, 2019
Blue Sea Capital, in partnership with SignatureMD management, has made a significant investment to acquire SignatureMD, a Marina del Rey–headquartered provider of concierge medicine support services. Financing for the transaction was provided by Five Points Capital via unitranche debt and an equity co-investment to support growth and geographic expansion.
- Buyers
- Blue Sea Capital, Five Points Capital, SignatureMD management
- Targets
- SignatureMD
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Blue Sea Capital Backs Merger of SignatureMD and Paragon
April 22, 2020
Healthcare Services
SignatureMD and Paragon Private Health merged in partnership with management and private equity firm Blue Sea Capital to create a leading provider of membership-based concierge medicine support services. The combined company operates under the SignatureMD and Paragon brands, supporting over 160 affiliated physicians across 31 states and prioritizing expansion of services such as telehealth and remote monitoring.
-
SignatureMD Merges with Cypress Membership Medicine; Backed by Blue Sea Capital
April 2, 2021
Healthcare Services
SignatureMD and Cypress Membership Medicine have merged in a transaction supported by SignatureMD management and private equity firm Blue Sea Capital. The combination creates one of the nation’s largest concierge medicine platforms—bringing together over 200 affiliated physicians across 35 states—and aims to accelerate growth, expand services, and enhance support for affiliated physicians and members.
-
Blue Sea Capital Forms Beacon Oral Specialists with Atlanta Oral & Facial Surgery and Bay Area Oral Surgery Management
December 14, 2020
Healthcare Services
Blue Sea Capital has made a substantial growth investment to form Beacon Oral Specialists, a management services organization that will support Atlanta Oral & Facial Surgery (AOFS) and Bay Area Oral Surgery Management (BAOSM). The affiliation creates a national oral surgery platform spanning roughly 37 clinic locations and nearly 40 oral surgeons, enabling the surgeon-led practices to retain clinical roles while receiving centralized administrative, billing, IT and marketing support to accelerate growth.
-
Partners Group and Portobello Capital Acquire Majority Stake in BLUESEA Hotels
November 20, 2024
Real Estate
Partners Group, alongside Portobello Capital, has acquired a majority stake in BLUESEA Hotels, a Palma de Mallorca–headquartered hospitality platform that owns and operates 25 hotels (around 5,100 rooms) across Spain. The investors plan a transformational value-creation program including refurbishments, operational improvements and strategic acquisitions to grow BLUESEA's platform in key Spanish tourist destinations.
-
Blue Sea Capital Acquires MicroCare
August 13, 2025
Manufacturing
Blue Sea Capital has acquired MicroCare Holdings, LLC, a New Britain, Connecticut-based maker of precision cleaning consumables for healthcare, aerospace & defense, data centers, electronics and other critical markets. Terms were not disclosed; the transaction represents an exit by Heartwood Partners (Fund III) and positions MicroCare for accelerated product development, organic growth and complementary add-on acquisitions under Blue Sea's ownership.
-
Blue Sea Capital Acquires WillowWood Global from DW Healthcare Partners
December 6, 2021
Medical Devices
Blue Sea Capital has completed an acquisition of WillowWood Global LLC, a long-established designer and manufacturer of prosthetic products, from DW Healthcare Partners. The investment positions WillowWood for accelerated growth — with management retaining meaningful ownership — and signals Blue Sea's intent to support organic growth and pursue acquisition-driven expansion in the prosthetics market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.